NPPB and hydrops fetalis: Galectin-3 has been found to be useful in predicting mortality in patients with HF in conjunction with NT-proBNP [17], but NT-proBNP and sST2 are likely superior to galectin-3 for prognostication purposes in patients with chronic HF [18].